Araris Biotech (Acquisition)
Funding Details
- Date Award
- May 18, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Valuation
- $740,000,000
- Funding Amount:
- $400,000,000
Company Info
- Organizations Involved
- Taiho Pharmaceutical
- Company Description
- Araris Biotech is known for developing innovative antibody-drug conjugates (ADCs) and is being acquired by Taiho Pharmaceutical to accelerate ADC drug discovery.
- Market
- Oncology
- Location
- Switzerland